Iodinated Contrast Media in Interventional X-Ray Market (COVID-19) to Witness Astonishing Growth by Forecast 2020-2027

1
Iodinated Contrast Media in Interventional X-Ray
Market (COVID-19) to Witness Astonishing Growth
by Forecast 2020-2027
Iodinated Contrast Media in Interventional X-Ray
Market By Route of Administration (Intravenous,
Oral, Rectal, Others), Indication (Cardiology,
Neurology, General Surgery, Oncology, Urology),
Agent Type (Non-Ionic, Ionic), End User
(Hospital, Specialty Clinics, Diagnostic Centers,
Ambulatory Surgical Centers, Research Academic
Institutes), Country ( U.S., Canada, Mexico,,
Germany, U.K., France, Italy, Spain, Switzerland,
Netherlands, Russia, Belgium, Turkey, Rest Of
Europe, China, Japan, South Korea, India,
Australia, Singapore, Thailand, Malaysia,
Indonesia, Philippines, Rest of Asia-Pacific,
Brazil, Argentina, Peru, Rest of South America,
UAE, Saudi Arabia, Egypt, South Africa, Israel,
Rest of Middle East and Africa) Market Trends and
 Forecast to 2027
Browse Full Report https//www.databridgemarke
tresearch.com/reports/global-iodinated-contrast-me
dia-in-interventional-x-ray-market
2
Report Description
Iodinated contrast media in Interventional X-ray
market is expected to gain market growth in the
forecast period of 2020 to 2027. Data Bridge
Market Research analyses that the market is
growing with a CAGR of 5.3 in the forecast
period of 2020 to 2027and expected to reach USD
3,160.98 million by 2027 from USD 2,108.76
million in 2019. Large number of approvals for
iodinated agents and increasing number of chronic
diseases is driving the iodinated contrast media
in interventional x-ray market. Increasing
prevalence of chronic disease such as growing
preference for interventional diagnosis across
the globe has increased the adoption of iodinated
contrast media. For instance, According to World
Health Organization, there were an estimated 17.9
million deaths in 2016 due to cardiovascular
diseases cardiovascular diseases are one of the
main causes of deaths around the world.
Browse Full TOC https//www.databridgemarketre
search.com/toc/?dbmrglobal-iodinated-contrast-med
ia-in-interventional-x-ray-market
3
Major Key Players

• Some of the major players operating in this
  market are
• Bayer AG
• Iso-Tex Diagnostics, Inc.
• Bracco Diagnostic Inc.
• Novalek Pharmaceuticals Pvt. Ltd.
• iMAX
• Taejoon Pharm
• Unijules Medicals Ltd
• General Electric
• Guerbet LLC

Inquire Before Buying https//www.databridgemark
etresearch.com/inquire-before-buying/?dbmrglobal-
iodinated-contrast-media-in-interventional-x-ray-m
arket
4
Market Segmentation

• By Route of Administration (Intravenous, Oral,
  Rectal, Others)
• By Indication (Cardiology, Neurology, General
  Surgery, Oncology, Urology)
• By End User (Hospital, Specialty Clinics,
  Diagnostic Centers, Ambulatory Surgical Centers,
  Research Academic Institutes)

Get Exclusive Sample Report _at_ https//www.databri
dgemarketresearch.com/request-a-sample/?dbmrgloba
l-iodinated-contrast-media-in-interventional-x-ray
-market
5
Regional Analysis

• Based on geography, the market is segmented into
  five geographical regions
• North America
• Europe
• Asia-Pacific
• South America
• Middle East
• Africa

6
About Data Bridge Market Research
An absolute way to forecast what future holds is
to comprehend the trend today! Data Bridge Market
Research set forth itself as an unconventional
and neoteric Market research and consulting firm
with unparalleled level of resilience and
integrated approaches. We are determined to
unearth  the best market opportunities and foster
efficient information for your business to thrive
in the market. Data Bridge endeavors to provide
appropriate solutions to the complex business
challenges and initiates an effortless
decision-making process. Read Continue
http//databridgemarketresearch.com/about-us/
Contact Us Sopan Gedam Sopan.gedam_at_databridge
marketresearch.com